Sort
82,697 grants matching “vaccine development”
Interactions between the ADORA2b/Sphk1axis and the AE1-Hb switch in red blood cell aging in vivo and in vitro
$730,338Angelo D'alessandro · University Of Colorado Denver · R01 · FY2020 · HL
Detection of asymptomatic Salmonella enterica serotype Typhi and Paratyphi A carriage by serum antibodies targeting YncE
$730,315Richelle C Charles · Massachusetts General Hospital · R01 · FY2018 · AI
Antibody mediated immunity against Klebsiella pneumoniae
$730,301Jason B Harris · Massachusetts General Hospital · R01 · FY2024 · AI
Exploiting Vulnerability on Influenza Virus
$730,213Ian A Wilson · Scripps Research Institute, The · R56 · FY2017 · AI
Neutralizing and non-neutralizing antibody effector functions in HIV infected children
$730,146Genevieve Giny Fouda Amou Ou · Duke University · R01 · FY2020 · AI
Development of dual inhibitors targeting the viral main protease and the host cathepsin L as SARS-CoV-2 antivirals
$730,106Jun Wang · Rutgers Biomedical And Health Sciences · R01 · FY2023 · AI
Mechanisms of BNT162b2 Vaccine Immunogenicity in Systemic Lupus Erythematosus or Scleroderma
$729,999Paul Joseph Utz · Stanford University · R01 · FY2025 · AI
Novel HIV-1 Env trimer probes for efficient isolation of broadly neutralizing antibodies
$729,983Xueling Wu · Aaron Diamond Aids Research Center · R01 · FY2016 · AI
Squirrel Monkey Breeding and Research Resource
$729,952Christian R Abee · University Of Tx Md Anderson Can Ctr · P40 · FY2017 · OD
Prevention and Treatment of Pneumocystis Pneumonia
$729,942Karen A Norris · University Of Georgia · R01 · FY2021 · AI
Prevention and Treatment of Pneumocystis Pneumonia
$729,942Karen A Norris · University Of Georgia · R01 · FY2022 · AI
Sex specific immune response to SARS-CoV-2 leads to chronic neurologic symptoms
$729,940Louise Deborah McCullough · University Of Texas Hlth Sci Ctr Houston · R01 · FY2022 · MH
Influence of maternal virome and HIV status on infant gut virome, growth and immunity
$729,928Heather Beryl Jaspan · Seattle Children'S Hospital · R01 · FY2024 · HD
Integration of adjuvant derived nanoparticles and engineered mRNA for HIV vaccine discovery
$729,905Yizhou Dong · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · AI
Preclinical-Clinical Paramyxovirus Vaccine Development
$729,821Allen Portner · St. Jude Children'S Research Hospital · P01 · FY2006 · AI
Combination nanovaccine-based immunization against influenza virus in the aged: immunity and protection
$729,805Marian L Kohut · Iowa State University · R01 · FY2021 · AI
Project 2. Animal studies to elucidate the optimal sequence of Env immunogens for induction of distal MPER bnAbs
$729,758S Munir Alam · Duke University · P01 · FY2019 · AI
Development of botulinum neurotoxin immunotherapy, serotypes C, D, F, and G
$729,744James D. Marks · University Of California, San Francisco · U01 · FY2007 · AI
VACCINE DISCOVERY FOR TRYPANOSOMA CRUZI
$729,701University Of Georgia (Uga) · P01 · FY2001 · AI
Influence of HIV infection on vaginal virome and risk of preterm birth in pregnant South African women
$729,641Heather Beryl Jaspan · Seattle Children'S Hospital · R01 · FY2025 · HD
MUC16 Antibody Based Strategies for Imaging and Therapy
$729,636David R Spriggs · Sloan-Kettering Inst Can Research · P01 · FY2017 · CA
MUC16 Antibody Based Strategies for Imaging and Therapy
$729,636David R Spriggs · Sloan-Kettering Inst Can Research · P01 · FY2018 · CA
Antibody Responses in HIV and Aging
$729,584Savita Pahwa · University Of Miami School Of Medicine · R01 · FY2015 · AI
3D Models of Immunotherapy
$729,562David J Mooney · Harvard University · U01 · FY2018 · CA
Genetic Markers of Long-Term Mumps Vaccine Immunity
$729,502Richard B Kennedy · Mayo Clinic Rochester · R01 · FY2019 · AI